70
Participants
Start Date
November 30, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
June 30, 2015
Convalescent Plasma Treatment
This pilot trial will treat subjects in the ECP Group with ECP derived from two donors. ECP will be provided as ECPSDU each comprising 90 - 110mL of plasma from two individual ABO-compatible donors. Two ECPSDU will be administered as immediately sequential infusions. Subjects may receive up to three doses of ECP not less than 48 hours apart. ECP will be provided as Plasma Frozen Within 24 Hours After Phlebotomy (PF24).
RECRUITING
ELWA-2 Ebola Treatment Unit, Monrovia
Lead Sponsor
Clinical Research Management, Inc.
INDUSTRY